WALD Overview

Waldencast plc is a global multi-brand beauty and wellness platform. It is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical segment sells advanced skincare products backed by science and formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and to protect and enhance skin tone and texture. Its portfolio of medical-grade skincare with consumer-centric, in-office injectable procedures includes Saypha ChIQ, and MagIQ lines of injectable hyaluronic acid gels. The Milk Makeup segment consists of the business of Milk. Its Milk’s business activities include developing, marketing, and selling cosmetics, skincare, and other beauty products. Its Milk Makeup segment offers over 250 products through its United States Website www.MilkMakeup.com and retail partners include Sephora globally and Ulta Beauty in the United States.

Wall Street analysts forecast WALD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WALD is3.75 USD with a low forecast of 3.50 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Waldencast PLC revenue for the last quarter amounts to 65.44M USD, decreased

Waldencast PLC. EPS for the last quarter amounts to USD, decreased

Waldencast PLC (WALD) has 364 emplpoyees as of May 12 2026.

Today WALD has the market capitalization of 230.87M USD.